Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial - Maher, T M; Corte, T J; Fischer, A (The Lancet Respiratory Medicine, 2020)
et al.